Preclinical/early clinical contract research organization MPI Research has entered into a partnership with InviCRO and 3D Imaging to establish a new molecular imaging center for drug discovery and development.
The center will be located at MPI Research's facility in Mattawan, MI. It will provide drug developers with access to the first commercially available cyclotron facility that is immediately contiguous with facilities housing species ranging from mice to nonhuman primates, according to MPI Research. The site is expected to open in the second quarter of 2014.
